Empirical antifungal therapy of febrile neutropenia in patients with hematologic malignancies - experts advice - with the support of CELL, CHS JEP COS, SCHS SLS

Abstract

New consensus of expert is presented for the selection of antifungal agents for empirical treatment of febrile neutropenia in patients with hematological malignancy.

Keywords

• invasive fungal infection
• empirici antifungal therapy
• fibrile neutropenia
• hematological malignancy